Feasibility and safety of temporary subcutaneous venous figure-of-eight suture to achieve haemostasis after ablation of atrial fibrillation

Europace

Volumn 18, Issue 6, 2016, Pages 815-819

  Traullé, Sarah ^a   Kubala, Maciej ^a   Doucy, Alexandre ^a   Quenum, Serge ^a   Hermida, Jean Sylvain ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

Ablation; Atrial fibrillation; Complications; Haematoma; Haemostasis; Suture technique

Indexed keywords

ANTIVITAMIN K; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; ANTICOAGULANT AGENT;

ABLATION CATHETER; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; ATRIAL FIBRILLATION; CATHETER ABLATION; CATHETER SHEATH; CREATININE CLEARANCE; CRYOTHERAPY; FEASIBILITY STUDY; FEMALE; HEMATOMA; HEMOSTASIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; PAROXYSMAL ATRIAL FIBRILLATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SUTURING METHOD; FRANCE; HEMORRHAGE; INCIDENCE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK FACTOR; SUTURE TECHNIQUE; THROMBOEMBOLISM; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CATHETER ABLATION; FEASIBILITY STUDIES; FEMALE; FRANCE; HEMATOMA; HEMORRHAGE; HEMOSTASIS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK FACTORS; SUTURE TECHNIQUES; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 84983749098     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euv266     Document Type: Article

References (12)

1. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012;14:528-606.
2. Ghaye B, Szapiro D, Dacher JN, Rodriguez LM, Timmermans C, Devillers D et al. Percutaneous ablation for atrial fibrillation: the role of cross-sectional imaging. Radiographics 2003;23 Spec No:S19-33;discussion S48-50.
3. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010;3:32-8.
4. Shaw JA, Dewire E, Nugent A, Eisenhauer AC. Use of suture-mediated vascular closure devices for the management of femoral vein access after transcatheter procedures. Catheter Cardiovasc Interv 2004;63:439-43.
5. Ilias M, Sakata Y, Salinger M, Sanborn TA, Feldman T. The use of percutaneous suture mediated closure for the management of 14-French femoral venous access. J Invasive Cardiol 2006;18:299-302.
6. Bagai J, Zhao D. Subcutaneous "Figure-of-Eight" stitch to achieve hemostasis after removal of large-caliber femoral venous sheaths. Cardiac Interv Today 2008:22-3.
7. Hussein AA, Martin DO, Saliba W, Patel D, Karim S, Batal O et al. Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: a safe and efficacious periprocedural anticoagulation strategy. Heart Rhythm 2009;6: 1425-29.
8. Hakalahti A, Uusimaa P, Ylitalo K, Raatikainen MJ. Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment. Europace 2011; 13:640-5.
9. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 2011;123: 2736-47.
10. Guiot A, Savouré A, Godin B, Anselme F. Collateral nervous damages after cryoballoon pulmonary vein isolation. J Cardiovasc Electrophysiol 2012;23: 346-51.
11. Shah RU, Freeman JV, Shilane D, Wang PJ, Go AS, Hlatky MA. Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. J Am Coll Cardiol 2012;59:143-9.
12. Conte G, De Asmundis C, Baltogiannis G, Di Giovanni G, Ciconte G, Sieira J et al. Periprocedural outcomes of prophylactic protamine administration for reversal of heparin after cryoballoon ablation of atrial fibrillation. J Interv Card Electrophysiol 2014;41:129-34.